AIM2 and breast cancer: In breast cancer, overexpression of AIM2 can decrease the expression of the anti-apoptotic protein Bcl-xl, increase the expression of the pro-apoptotic Bax, and induce the cleavage of the DNA repair protein PARP, thus leading to breast cancer cell apoptosis and the inhibition of breast cancer progression (45).